Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: Results of a survey of long-term care practitioners

被引:128
作者
Monette, J
Gurwitz, JH
Rochon, PA
Avorn, J
机构
[1] MEYERS PRIMARY CARE INST, WORCESTER, MA 01608 USA
[2] BRIGHAM & WOMENS HOSP, DEPT MED, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, BOSTON, MA USA
[4] FALLON HEALTHCARE SYST, WORCESTER, MA USA
[5] UNIV MASSACHUSETTS, MED CTR, WORCESTER, MA USA
[6] UNIV TORONTO, TORONTO, ON, CANADA
[7] BAYCREST CTR GERIAT CARE, TORONTO, ON, CANADA
关键词
ORAL ANTICOAGULANT-THERAPY; BLEEDING COMPLICATIONS; ELDERLY PATIENTS; RISK-FACTORS; OUTPATIENTS;
D O I
10.1111/j.1532-5415.1997.tb05967.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
BACKGROUND: The prevalence of atrial fibrillation (AF) increases dramatically with advancing patient age, and, as a result, this condition is common in persons residing in the long-term care setting. OBJECTIVES: To assess the knowledge and attitudes of physicians regarding the use of warfarin for stroke prevention in patients with atrial fibrillation in long-term care facilities. METHODS: We surveyed physicians actively providing primary care to older patients in 30 long-term care facilities located in New England, Quebec, and Ontario. Physicians were requested to complete a structured questionnaire about use of warfarin therapy for stroke prevention in patients with AF residing in long-term care facilities. The questionnaire included two clinical scenarios designed to provide substantial contrasts in patient characteristics including underlying comorbidity, functional status, bleeding risk, and stroke risk. RESULTS: A total of 269 physicians were asked to participate in the survey, and 182 (67.7%) completed the questionnaire between February 1, 1995, and July 31, 1995. Only 47% of respondents indicated that the benefits of warfarin therapy ''greatly outweigh the risks'' in this setting; the remainder of physicians indicated that benefits only ''slightly outweigh the risks'' (34%) or that risks ''outweigh benefits'' (19%). The most frequently cited contraindications to warfarin use were: excessive risk of falls (71%), history of gastrointestinal bleeding (71%), history of other non-central nervous system bleeding (36%), and history of cerebrovascular hemorrhage (25%). Among the 164 physicians who reported using the international normalized ratio to monitor warfarin therapy, 27% indicated a target range with a lower limit less than 2, 71% indicated a target range between 2 and 3, and 2% indicated an upper limit greater than 3. Among respondents who answered questions about the two clinical scenarios, estimates of the risk of a stroke without warfarin therapy and the risk of an intracranial hemorrhage with therapy varied widely. CONCLUSIONS: Our findings suggest that many uncertainties surround the decision to prescribe warfarin to patients with AF in the long-term care setting, as well as questions about the appropriate intensity of this treatment when it is prescribed. Concerns about the risks of bleeding appear to prevail over stroke prevention when physicians make such prescribing decisions.
引用
收藏
页码:1060 / 1065
页数:6
相关论文
共 29 条
  • [1] OMISSION BIAS AND PERTUSSIS VACCINATION
    ASCH, DA
    BARON, J
    HERSHEY, JC
    KUNREUTHER, H
    MESZAROS, J
    RITOV, I
    SPRANCA, M
    [J]. MEDICAL DECISION MAKING, 1994, 14 (02) : 118 - 123
  • [2] PHYSICIANS ATTITUDES TO 4 COMMON PROBLEMS - HYPERTENSION, ATRIAL-FIBRILLATION, TRANSIENT ISCHEMIC ATTACKS, AND ANGINA-PECTORIS
    BUCKNALL, CA
    MORRIS, GK
    MITCHELL, JRA
    [J]. BRITISH MEDICAL JOURNAL, 1986, 293 (6549) : 739 - 742
  • [3] CHANG HJ, 1990, ARCH INTERN MED, V150, P81
  • [4] ANTICOAGULATION IN PATIENTS WITH ATRIAL-FIBRILLATION - UNDERUSE OF WARFARIN IS MULTIFACTORIAL
    DOW, L
    BERTAGNE, B
    [J]. BRITISH MEDICAL JOURNAL, 1993, 307 (6917) : 1492 - 1493
  • [5] PREVALENCE, AGE DISTRIBUTION, AND GENDER OF PATIENTS WITH ATRIAL-FIBRILLATION - ANALYSIS AND IMPLICATIONS
    FEINBERG, WM
    BLACKSHEAR, JL
    LAUPACIS, A
    KRONMAL, R
    HART, RG
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (05) : 469 - 473
  • [6] The risk for and severity of bleeding complications in elderly patients treated with warfarin
    Fihn, SD
    Callahan, CM
    Martin, DC
    McDonell, MB
    Henikoff, JG
    White, RH
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 124 (11) : 970 - +
  • [7] RISK-FACTORS FOR COMPLICATIONS OF CHRONIC ANTICOAGULATION - A MULTICENTER STUDY
    FIHN, SD
    MCDONELL, M
    MARTIN, D
    HENIKOFF, J
    VERMES, D
    KENT, D
    WHITE, RH
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (07) : 511 - 520
  • [8] Atrial fibrillation and stroke prevention with warfarin in the long-term care setting
    Gurwitz, JH
    Monette, J
    Rochon, PA
    Eckler, MA
    Avorn, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (09) : 978 - 984
  • [9] AGE-RELATED RISKS OF LONG-TERM ORAL ANTICOAGULANT-THERAPY
    GURWITZ, JH
    GOLDBERG, RJ
    HOLDEN, A
    KNAPIC, N
    ANSELL, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (08) : 1733 - 1736
  • [10] RISK-FACTORS FAR INTRACRANIAL HEMORRHAGE IN OUTPATIENTS TAKING WARFARIN
    HYLEK, EM
    SINGER, DE
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (11) : 897 - 902